uMed: uMed: First of its kind patient cohort program announced at IPF-Summit
NEW YORK, Aug. 29, 2022announced the launch of the Access-ILD/PF Cohort at the sixth annual Idiopathic Pulmonary Fibrosis (IPF) Summit in Boston. uMed has built a technology that can rapidly identi...
Read full article »
uMed is an England-based health-tech platform that enables life sciences and medical teams to recruit patients into clinical trials.
Read more